FDG PET and PET/CT imaging in lymphoma and melanoma

被引：21

作者：

Macapinlac, HA ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Div Diagnost Imaging, Houston, TX 77030 USA

来源：

CANCER JOURNAL | 2004年 / 10卷 / 04期

关键词：

curative radiation; tumor; functional imaging;

D O I：

10.1097/00130404-200407000-00007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

FDG PET imaging is rapidly gaining acceptance in numerous clinical applications in oncology. PET/CT is a new imaging tool, which takes advantage of the excellent anatomic resolution of CT and the biologic characterization provided by FDG PET which together results in improvement in accuracy of detecting the extent of disease, provide a guide to biopsy or surgery, allow early response evaluation and prognostication. This article will provide specific clinical applications for the utilization of these imaging modalities in both lymphoma and melanoma.

引用

页码：262 / 270

页数：9

共 26 条

[1]

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].

Balch, CM ;

Buzaid, AC ;

Soong, SJ ;

Atkins, MB ;

Cascinelli, N ;

Coit, DG ;

Fleming, ID ;

Gershenwald, JE ;

Houghton, A ;

Kirkwood, JM ;

McMasters, KM ;

Mihm, MF ;

Morton, DL ;

Reintgen, DS ;

Ross, MI ;

Sober, A ;

Thompson, JA ;

Thompson, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648

[2]

Bangerter M, 1999, ACTA ONCOL, V38, P799

[3]

Bangerter M., 1999, RADIOGRAPHY, V5, P155

[4]

Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin [J].

Blodgett, TM ;

Ames, JT ;

Torok, FS ;

McCook, BM ;

Meltzer, CC .

CLINICAL NUCLEAR MEDICINE, 2004, 29 (03) :161-163

[5]

Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].

Bos, R ;

van der Hoeven, JJM ;

van der Wall, E ;

van der Groep, P ;

van Diest, PJ ;

Comans, EFI ;

Joshi, U ;

Semenza, GL ;

Hoekstra, OS ;

Lammertsma, AA ;

Molthoff, CFM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387

[6]

CINKELSTEIN SE, 2004, ANN SURG ONCOL, V11, P731

[7]

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma [J].

Cremerius, U ;

Fabry, U ;

Neuerburg, J ;

Zimny, M ;

Osieka, R ;

Buell, U .

NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (11) :1055-1063

[8]

Crippa F, 2000, J NUCL MED, V41, P1491

[9]

FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo hodgkin lymphoma:: A blinded comparison [J].

Friedberg, JW ;

Fischman, A ;

Neuberg, D ;

Kim, H ;

Takvorian, T ;

Ng, AK ;

Mauch, PM ;

Canellos, GP ;

Van den Abbeele, AD .

LEUKEMIA & LYMPHOMA, 2004, 45 (01) :85-92

[10]

GRITTERS LS, 1993, J NUCL MED, V34, P1420

← 1 2 3 →